Brief: Shenzhen Neptunus Interlong Bio-Technique's unit enters sales management service deal
01/09/2017 10:37
Sept 1 (Reuters) - Shenzhen Neptunus Interlong Bio-technique
Co Ltd 8329.HK
* Neptunus Changjian entered into sales management service
framework agreement with Neptunus Pharmaceutical
* Neptunus Changjian to provide sales management service of
pharmaceutical products to Neptunus Pharmaceutical
Source text (http://bit.ly/2euEu7O)
Further company coverage: 8329.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million